Guidance for Researchers
As restrictions surrounding coronavirus begin to ease, we are planning to expand laboratory and human subject research activities. We anticipate a gradual resumption of research activity beginning on May 18, in line with Governor Cuomo’s directive, however a return to “normal” activity is unlikely for many months or longer.
Please note: Clinical researchers must complete a study interest form before pursuing COVID-19 human subjects research studies, including interventional clinical trials and observational studies. A central team is working to ensure URMC offers studies that best suit our patient populations, harmonizes access to study populations, and helps synergize URMC COVID-19 research response efforts.
The University of Rochester (UR) and Medical Center (URMC) are closely monitoring the evolving COVID-19 situation and developing policies to keep students, faculty, and staff safe. Some of those policies will impact research operations and require specific guidance to help us maintain operations while keeping our research community safe. The tabs below provide specific guidance for Human Subjects, Laboratory and Animal Research as well as COVID-19-related research funding opportunities.
This is a rapidly changing situation, so please check back frequently. We will be updating and adding information as it becomes available. If you have a questions regarding COVID-19 and research (policies, opportunities for collaboration, etc.), please direct them to the UR CTSI’s Research Help Desk.
If you would like to volunteer to help with COVID-19 research or clinical efforts, please fill out this brief survey.
If you are in need of services, equipment or supplies (peruse over 30 available reagents) for a COVID-19 research study, please contact ResearchHelp@URMC.rochester.edu.